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Abstract
Background: To compare health related quality of life (HR-QoL) in patients surgically treated for
secondary peritonitis to that of a healthy population. And to prospectively identify factors
associated with poorer (lower) HR-QoL.
Design: A prospective cohort of secondary peritonitis patients was mailed the EQ-5D and EQ-
VAS 6-months following initial laparotomy.
Setting: Multicenter study in two academic and seven regional teaching hospitals.
Patients: 130 of the 155 eligible patients (84%) responded to the HR-QoL questionnaires.
Results: HR-QoL was significantly worse on all dimensions in peritonitis patients than in a healthy
reference population. Peritonitis characteristics at initial presentation were not associated with
HR-QoL at six months. A more complicated course of the disease leading to longer hospitalization
times and patients with an enterostomy had a negative impact on the mobility (p = 0.02), self-care
(p < 0.001) and daily activities: (p = 0.01). In a multivariate analysis for the EQ-VAS every doubling
of hospital stay decreases the EQ-VAS by 3.8 points (p = 0.015). Morbidity during the six-month
follow-up was not found to be predictive for the EQ-5D or EQ-VAS.
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Conclusion: Six months following initial surgery, patients with secondary peritonitis report more
problems in HR-QoL than a healthy reference population. Unfavorable disease characteristics at
initial presentation were not predictive for poorer HR-QoL, but a more complicated course of the
disease was most predictive of HR-QoL at 6 months.
Background
Secondary peritonitis has a high in-hospital mortality
(24–35%), continued high post-hospital discharge mor-
tality, as well as a considerable long-term morbidity [1-5].
Patients are hospitalized for extensive periods of time and
often endure lengthy intensive care unit (ICU) stays [5-
12].
Recently, improving Health Related Quality of Life (HR-
QoL) in patients with sepsis [11,13,14] has become a
complementary goal in patient care [15]. The importance
of HR-QoL will continue to grow with improvement in
peritonitis survival. Till now, most HR-QoL data in sec-
ondary peritonitis and abdominal sepsis have been col-
lected retrospectively [4,13,14,16,17]. These studies have
shown that peritonitis patients suffer from HR-QoL
impairments both in the short-term as well as the long-
term. Good quality data from prospective studies are nec-
essary to identify factors related to lower HR-QoL. Insight
into these factors is needed to inform patients, to develop
preventive measures for high-risk patients, and to provide
tailored support for individual patients.
The aims of this study were twofold. Firstly, to assess HR-
QoL in patients with secondary peritonitis, and to com-
pare this with HR-QoL reported for a general reference
population [18]. And secondly, to determine which fac-
tors (patient, peritonitis and postoperative) are related to
HR-QoL six months following patients with severe sec-
ondary peritonitis (APACHE II > 10)[19,20].
Methods
Study design
This study was embedded in an ongoing peritonitis trial
evaluating two surgical strategies for patients with perito-
nitis, initiated by the Academic Medical Center (AMC),
Amsterdam, The Netherlands. Patients were enrolled
between December 2001 and August 2005 in 2 academic
and 7 regional teaching hospitals in The Netherlands.
Patients
Patients were eligible for the RELAP trial if they had a clin-
ical diagnosis of secondary peritonitis requiring emer-
gency laparotomy. Peritonitis had to be caused by
perforation or infection of a visceral organ, or ischemia/
necrosis of part of the gastrointestinal tract or postopera-
tive peritoneal infection. An Acute Physiology And
Chronic Health Evaluation (APACHE)-II score above 10
was required, as the preferred strategy for mild peritonitis
(APACHE-II score ≤ 10) is on-demand. Exclusion criteria
included: age below 18 or above 80; peritonitis due to
bowel perforation after endoscopy operated within 24
hours; abdominal infection due to indwelling dialysis
(CAPD) catheter; acute pancreatitis; expected survival of
less than 6 months due to disseminated malignancy;
severe brain damage due to trauma or anoxia; imperative
relaparotomy (gauze packing).
To be eligible for participation in the present HR-QoL
study, patients had to be alive and out of hospital at six
months following index laparotomy (Figure 1).
Instruments
HR-QoL was assessed approximately six months after the
index laparotomy by administering the patient self-report
Euroqol 5-Dimensions (EQ-5D) question which includes
five dimensions and the Euroqol-Visual Analogue Scale
(EQ-VAS) [21]. The Euroqol instruments have been exten-
sively validated, including Dutch healthy individuals, and
were recently recommended as the instrument of choice
in critical care studies [22-25]). EQ-5D was originally
designed to complement other instruments but is now
increasingly used as a 'stand alone' measure.
The EQ-5D measures five health dimensions: mobility
(MO), self-care (SC), daily activities (DA), pain/discom-
fort (PD), and mood (MD) consisting of both anxiety and
Flowchart summarizing inclusion and response Figure 1
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depression. In the EQ-5D patients report: 0 (no prob-
lems), 1 (moderate problems), and 2 (extreme problems)
[26]. Whilst the EQ-VAS is a thermometer-like scale, in
which patients rate their overall well-being from 0 (worst
imaginable overall health) to 100 (best imaginable over-
all health) [26,27].
Data collection
Preoperative risk factors and postoperative morbidity data
were prospectively collected for all eligible patients. HR-
QoL data were collected six months after index operation.
EQ-5D and EQ-VAS questionnaires were sent by mail to
patients who survived at least six months, with a reminder
by phone within two weeks if there was no response. After
one month without response patients were phoned and
then new set of questionnaires with a reminder letter were
sent.
Reference populations
We used measured with the same instrument for a sample




The proportion of peritonitis patients reporting moderate
or extreme problems (combined together) on each of the
EQ-5D dimensions in the study group was compared to
the proportion reported by the general Dutch population
using a χ2 tests. Differences in mean EQ-VAS scores were
calculated between the study peritonitis patients and the
general population stratified by 10-year age groups, and
tested for significance using the Student's t-test [26].
Representatively of the sample with HR-QoL measure-
ments for the non-responders (non-respondent analysis)
was evaluated using χ2 tests to compare categorical data,
and the Student's t-test or the Mann-Whitney U test for
continuous data.
Predictive factors
An initial set of potential factors was based on two previ-
ous studies examining factors associated with increased
mortality and morbidity in patients with secondary peri-
tonitis [5,13]. These candidate factors were divided into
three distinct categories:
1) General patient characteristics: age, gender, and having
one or more major comorbidities. Major comorbidities
were measured by severity and included cardiovascular
disease; chronic obstructive pulmonary disease (COPD);
malignancy; renal disease, and diabetes mellitus (DM).
2) Peritonitis characteristics: severity of disease at study
entry measured by the APACHE-II score and severity of
peritonitis measured by the Mannheim Peritonitis Index
(MPI), extent (localized versus diffuse) and type of con-
tamination (clear, turbid, purulent, fecal), etiology of
peritonitis (inflammation, perforation, ischemia/necro-
sis, anastomotic leakage), and community-acquired ver-
sus hospital-acquired or nosocomial infection, (these
infections include post-operative peritonitis as complica-
tion of a previous (elective) surgical intervention or peri-
tonitis that is the result of treatment in a hospital or
hospital-like setting)
3)  Postoperative characteristics: number of relaparoto-
mies, length of stay in ICU and hospital, duration of
mechanical ventilation, complications during ICU stay,
i.e., acute respiratory distress syndrome (ARDS). Also fac-
tors including having an enterostomy at six months, the
number of hospital readmissions (for peritonitis-related
morbidity) and experiencing one of the predefined severe
morbidities during the six-month follow-up (including
incisional hernia, bowel obstruction/herniation, burst
abdomen, abdominal compartment syndrome, fistula,
intra-abdominal bleeding, perforation, anastomotic leak-
age, ischemia/necrosis, enterostomy dysfunction, bleed-
ing ulcer, abscess (needing drainage), renal failure,
myocardial infarction/embolus/cerebral vascular acci-
dent, pneumonia or urosepsis needing readmission (see
Appendix 2 for the complete list)).
We used a general linear model to identify factors associ-
ated with the EQ-VAS, or with the proportion of patients
reporting moderate or severe problems on either of the
five dimensions of the EQ-5D. Factors associated with
HR-QoL (p <= 0.1) were then entered in a multivariate
model, unless predictive factors were strongly correlated
with each other, then only one factor with the strongest
association was chosen. The functional form of continu-
ous predictors was graphically assessed and, in the case of
pertinent non-linearity, a transformation was performed.
Statistical Package for the Social Sciences (SPSS 11.01,
SPSS Inc, Chicago, IL) was used for all data analysis.
Results
A total of 155 surviving patients were eligible for the HR-
QoL study and questionnaires were sent to all of them.
The overall response rate was 85% (130/155; see Figure
1). The average responses were provided at 6 months and
4 days after index laparotomy.
The mean age of patients at enrollment was 63 years, and
53% of the patients were male (Table 1). Patients at trial
entry were generally severely ill, as reflected by a mean
APACHE-II score of 15.1 and mean MPI of 19.9 (Table 1).Health and Quality of Life Outcomes 2007, 5:35 http://www.hqlo.com/content/5/1/35
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There was no significant difference in any patient baseline
characteristics; peritonitis characteristics or postoperative
characteristics between patients who responded to the
HR-QoL questionnaires (n = 130) and patients that did
not respond (n= 32) (Figure 1).
Comparison with other populations
Compared to a health reference population [18], the peri-
tonitis group reported significantly more problems on all
EQ-5D dimensions (p < 0.001 for all dimensions, see Fig-
ure 2). Patients with peritonitis showed in all age groups
lower EQ-VAS scores than the reference group, indicating
worse overall HR-QoL. In the RELAP group, EQ-VAS
scores appeared to be low from young till old and did not
particularly worsen for those who are older.
Predictive factors
Results of the univariate analyses evaluating patient, peri-
tonitis and postoperative factors as predictors for HR-QoL
at six months are reported in table 2.
General patient characteristics
In a univariate analysis men reported significantly fewer
problems with mobility and daily activities. Increasing
age decreased overall well-being and increased problems
in mobility, but was protective for mood problems with
younger patients scoring more mood problems. Major
comorbidities at baseline were predictive for more prob-
lems related to mobility and mood at six months (Table
2).
Peritonitis characteristics
Peritonitis characteristics were not associated with scores
on EQ-VAS or EQ-5D when looking at severity of disease
or peritonitis severity, etiology or type and extent of the
contamination (Table 2). There were no HR-QoL differ-
ences between patients with community-developed peri-
tonitis and patients with hospital-acquired peritonitis.
Percentage of HR-QoL problems reported by peritonitis  study patients (n = 130) compared to a general reference  population from The Netherlands (Dutch reference popula- tion) (n = 851) [18] by EQ-5D dimensions Figure 2
Percentage of HR-QoL problems reported by peritonitis 
study patients (n = 130) compared to a general reference 
population from The Netherlands (Dutch reference popula-
tion) (n = 851) [18] by EQ-5D dimensions.
Table 1: General patient, peritonitis and post-operative 
characteristics (n = 130)
Patient Characteristics (n= 
130)
Percentage
Age; mean (SD) 63 (14)
Males; n 70 53
≥1 major comorbidity; n 73 56
Peritonitis Characteristics
APACHE – II mean (SD) 15.1 (4.1)














Anastomotic leakage 41 31
Other 6 5
Hospital-acquired peritonitis 
patients (peritonitis following 




Pts with ≥1 relaparotomy n 86 66
Relaparotomies; median (range) 1.0 relaps (1–10)
Pts admitted to ICU n 115 88
Length of ICU stay; median 
(P25–P75)
9 days (6–21)
Patients ventilated n 110 84
Duration of ventilation; median, 
(P25–P75)
6 days (3–12)
Length of hospital stay median, 
(P25–P75)§
34 days (19–60)
Acute Respiratory Distress 
Syndrome (ARDS)
75 . 4
Patients readmitted ≥1 at 6 
months
74 57
>1 Morbidities during 6-month 
follow-up*
33 26
Patients with enterostomy at 6 
months
73 56
* Information on morbidities missing for one patient (n = 129)
§For two patients the exact hospital stay was unknown, due to 
transfer to other hospitalHealth and Quality of Life Outcomes 2007, 5:35 http://www.hqlo.com/content/5/1/35
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Postoperative characteristics
Patients who stayed longer in ICU and/or surgical hospi-
tal-ward reported more problems on all functional
impairment dimensions mobility, self-care and daily
activities and overall well-being, but not on the pain and
mood dimensions (Table 2). Although ICU stay and hos-
pital stay are clearly associated with HR-QoL, whilst in a
univariate analysis mechanical ventilation was not.
Readmissions during the six-month follow-up were also
associated with lower HR-QoL scores. Patients who still
had an enterostomy six-months following surgery
reported more problems in the functional impairment
dimensions: mobility, self-care and daily activities (the
combination these dimensions is often referred to as a
specific discipline within HR-QoL called activities in daily
life or ADL). Overall those patients reported more well-
being problems than patients without an enterostomy
(Table 2).
Multivariate analysis
The following factors were entered in the multivariate
analysis based on the results of the univariate association
(p ≤ 0.10) with HR-QoL with at least two of the five EQ-
5D dimensions or an effect on the EQ-VAS (Table 2): gen-
der, major comorbidity, enterostomy at six months,
length of ICU stay and length of hospital stay (a log2
transformation was done to create linearity) and severe
morbidity during follow-up. From the literature, it was
decided that age should always be added to the models,
irrespective of the univariate analyses [22,28-30]. ICU stay
and hospital stay were highly correlated (Spearman's R =
0.681) and therefore not both of the factors could be
added to the multivariate model. Length of hospital stay
was selected to best represent the accumulation of what a
patient underwent following secondary peritonitis, used
as an adequate proxy for poor patients recovery and
potential complications. The same set of factors were
included in all six models (the EQ-VAS: Table 3 and the
five EQ-5D dimensions: Table 4).
In the multivariate analysis the only independent factor
that was predictive for poorer worse overall patient well-
being, as measured by the EQ-VAS, was length of hospital
stay (log2 transformed); every doubling of the length of
hospital stay decreased the EQ-VAS (0–100) score by 3.8
points (p = 0.015, Table 3).
In the logistic models for each dimension of the EQ-5D
the following factors were predictive of HR-QoL (Table 4).
Females reported more mobility problems (OR = 2.9, p =
0.013), more problems in daily activities (OR = 3.7, p =
0.006) and more pain and discomfort (OR = 2.3, p =
0.037). Increasing age was associated with fewer problems
Table 2: Strength of univariate association between potential predictors and reporting problems on the EQ-VAS and on the EQ-5D on 
which inclusion in final multivariate model is based.
EQ-VAS EQ-5D
VAS Mobility Self-care Daily Activity Pain Mood Included into 
Multivariate model
Patient Characteristics
Gender - + - ++ - - Yes
Age ++ + - - - ++ Yes
Major Comorbidity - + - - - + Yes
Peritonitis characteristics
APACHE-II - - - + - - No
Mannheim Peritonitis Index - - - - - - No
Extent of contamination - - - - - - No
Etiology of peritonitis - - - - - - No
Hospital-acquired vs. community-acquired 
peritonitis
--- - - - No
Postoperative Characteristics
Pts with ≥1 Relaparotomy - - - - - - No
Acute Respiratory Distress Syndrome (ARDS) - - - + - - No
Length of ICU stay + ++ ++ + - + Yes
Length of ventilation + - - + - - Yes
Length of hospital stay ++ ++ ++ ++ - - Yes
Readmissions during follow-up - - - - - - No
Severe morbidity during 6 month follow-up 
(Appendix 2)
+-- + - + Yes
Enterostomy at 6 months + ++ + + - - Yes
+ Univariate significance (p < 0.10), ++ univariate significance < 0.05
- No univariate significance foundHealth and Quality of Life Outcomes 2007, 5:35 http://www.hqlo.com/content/5/1/35
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Table 4: Odds ratios for reporting moderate/severe problems on each of the dimensions of the EQ-5D. Results from multivariate 
model including all listed factors










OR P-value OR P-value OR P-value OR P-value OR P-value
Gender (Female) 2.9 0.013* 1.5 0.296 3.7 0.006* 2.3 0.030* 1.7 0.176
Age (per 10 years increase) 1.0 0.246 0.99 0.534 0.98 0.148 0.74 0.078 0.54 <0.001*
Patients with major comorbidity at study 
entry
2.0 0.120 0.92 0.848 1.1 0.782 1.8 0.151 3.6 0.007*
Every doubling of the length of hospital stay 1.6 0.020* 2.5 <0.001* 1.9 0.010* 1.1 0.537 0.91 0.649
Patients with severe morbidity during six 
month follow-up
0.71 0.484 0.58 0.294 0.83 0.719 2.4 0.065 2.0 0.130
Patients with an enterostomy at six months 2.8 0.016* 1.7 0.240 2.8 0.027* 1.2 0.613 1.5 0.320
Significant p < 0.05, bold
Patients report moderate and/or severe problems
Table 3: Impact of potential predictors on EQ-VAS scores. Results expressed as absolute changes in mean scores derived from 
multivariate model.
Euroqol Visual Analogue Scale (n = 127‡)
Mean difference in EQ-VAS score† P-value
Gender (Male vs. females) 4.0 0.193
Age (per 10 years increase) -2.9 0.348
Patients without major comorbidity at study entry 3.9 0.192
Every doubling of the length of hospital stay -3.8 0.015*
Patients without severe morbidity during six month follow-up 6.4 0.077
Patients with no enterostomy at six months 4.9 0.125
* Significant p < 0.05, bold
‡ Three patients were dropped due to missing VAS scores
† Lower EQ-VAS scores indicate poorer health status
with mood (OR = 0.54 per 10 years, p < 0.001); whilst
patients with a major comorbidity were more likely to
report problems on the mood dimension (OR = 3.6, p =
0.007).
Length of hospital stay was associated with more prob-
lems in all ADL dimensions; a doubling of the length of
hospital stay increased problems in mobility (OR = 1.6, p
= 0.02), self-care (OR = 2.5, p < 0.001) and daily activities
(OR = 1.9, p = 0.01). Whilst severe morbidity (as experi-
enced) during the six months follow-up was no longer
independently associated with lower HR-QoL in the mul-
tivariate model. However, longer hospital stay is in part
due to severe morbidity; so clinically it may not be possi-
ble to consider them apart.
Patients with an enterostomy at six-month follow-up
reported more problems for mobility (OR = 2.8, p =
0.016) and daily activities (OR = 2.8, p = 0.027), but not
for self-care or mood.
Discussion
This study shows that patients treated for secondary peri-
tonitis report considerably more complaints on all EQ-5D
dimensions six months after initial surgery than a general
reference population. Furthermore, HR-QoL at six
months was found to be associated with several patient
characteristics and particularly postoperative characteris-
tics, whereas factors directly related initial severity of peri-
tonitis did not affect HR-QoL. [11].
Comparisons with other populations
The comparison with a general reference population of
healthy individuals allows for a better understanding of
the extent of reduction in HR-QoL in this patient group.
To give an even better perspective of the extent of the HR-
QoL presented here we can compare our peritonitis
patient group to a group of general sepsis patients, who
were also measured at 6 months following ICU discharge
using the Euroqol questionnaire [11]. Comparing these
groups shows our peritonitis patients reported more prob-
lems with ADL, e.g. more problems with mobility andHealth and Quality of Life Outcomes 2007, 5:35 http://www.hqlo.com/content/5/1/35
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daily activities, despite having comparable APACHE-II
scores, hospital stay and length of ICU stay with the gen-
eral sepsis patients. This difference in ADL dimensions
could, at least in part, be explained by some extent of dis-
figuration and protracted wound healing following major
surgery for patients with peritonitis in contrast to patients
with sepsis (resulting from other causes). As well, the peri-
tonitis patients often have an enterostomy for a lengthy
period of time, which in this study has also been shown
to reduce patients' mobility and daily activities. In con-
trast, secondary peritonitis patients reported fewer mood
problems than patients with sepsis from other causes.
One possible factor that could account for this difference
is the higher mean age of our peritonitis population. In
this study and an earlier retrospective study we have
shown that older secondary peritonitis patients report
fewer mood problems [11,31].
Factors associated with lower HR-QoL
In our study, general patient characteristics played an
important role in the HR-QoL at 6 months follow-up.
Female patients were more likely to report problems with
overall HR-QoL, mobility, daily activities, pain and dis-
comfort and mood. Of the nine studies, involving survi-
vors of critical illness and intensive care patients as
reviewed by Dowdy et al. [20], associations between HR-
QOL and gender were found in only two studies [32,33].
Peritonitis patients showed a clear association between
increased age and improved emotional health, possibly
related to an adjusting process. Similar findings were
reported in other studies, showing that elderly patients
demonstrated more positive health attitudes than
younger survivors [11,22,30,31]. However, in a recent
review no significant associations were found between age
and mental health (SF-36), anxiety/depression (EQ-5D)
and/or psychosocial QoL [20].
Comorbidity, often an important determinant of health
outcomes, was frequently present in this patient group.
Patients with 1 or more major comorbidity reported sig-
nificantly more moods problems. In these analyses we
only considered major comorbidities, indicating a pre-
existent more severely compromised clinical condition.
Although, most patients also suffered from an underlying
disease (i.e., primary condition) or underwent a primary
procedure prior to their secondary peritonitis, these fac-
tors were not considered in major comorbidities. Primary
conditions are more likely to be the actual cause or part of
the etiology of the peritonitis than is an actual comorbid-
ity; these included malignancy, diverticulitis, Crohn's dis-
ease, ulceritis and colitis ulcerosa. Disease severity
measure by the APACHE-II has been shown to be an ade-
quate predictor for survival in abdominal sepsis patients
[2,5,33-35]. Studies relating disease severity with HR-
QOL studies have found mixed results; in some papers
preoperative severity of disease was a predictor of HR-QoL
[30,33,36-40], whilst others observed no correlation
[28,29,41-43]. In our study higher APACHE scores were
not associated with poorer HR-QoL. This absent relation
could be explained by the homogeneity of the sample
with respect to disease severity; only APACHE-II scores
higher than 10 were included in the study, reflecting
severe illness with an expected mortality around 30%
[35]. In this spectrum of severe illness the variability in
APACHE-II might be insufficient to predict future HR-
QoL.
We found no relation between initial peritonitis severity
(MPI), extent or type of contamination and the etiology of
the peritonitis and HR-QoL at six months. This indicates
that the HR-QoL outcome of the most severe peritonitis
patients may in some cases be far better than anticipated
during the initial phase. For example, if a peritonitis
patient is admitted to the ICU with a high MPI score and
has a diffuse fecal peritonitis then, conditional on sur-
vival, their HR-QoL at 6 months follow-up may be similar
to those patients that were admitted with less severe peri-
tonitis. This indicates that although these factors are indi-
cators of mortality and morbidity, by themselves they are
not associated with poorer HR-QoL at 6 months. As well,
HR-QoL differences were not found between patients
with community-developed peritonitis and patients with
nosocomial peritonitis.
In this study the strongest factor associated with lower
HR-QoL was length of hospitalization. This suggests that
an extended and more complicated course of disease with
longer ICU stay combined with severe morbidity accumu-
lates into worse quality of life, most notably in problems
with mobility, self-care, and daily activities. ADL prob-
lems were primarily related to an extended course of dis-
ease encountered during the hospital stay with longer ICU
stay – likely related to an accumulation of factors, for
example more severe organ dysfunction, such as ARDS,
MOF, septic shock and critical illness neuropathy and
depended on the patients' response to peritonitis – rather
than the underlying etiology and extent of the peritonitis
at presentation.
Contrary to expectations, experiencing disease-related
morbidity during the six-month follow-up on its own was
not an independent predictor for EQ-5D or EQ-VAS out-
comes. This is partially due to the multivariate nature of
our analysis, where length of hospital probably includes
ICU stay in what it measures. Findings in the literature on
the relation between length of hospital or length of ICU
stay and HR-QoL vary: some studies also found that
length of stay was strongly related to HR-QoLHealth and Quality of Life Outcomes 2007, 5:35 http://www.hqlo.com/content/5/1/35
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[22,29,30,33,40], while other studies found no relation
[20,44].
Another particular sequel of the disease is having an enter-
ostomy constructed at surgery for peritonitis, which in
these patients is usually still present at six months follow-
up. As expected, patients with an enterostomy reported
more problems with mobility and daily activities. Reduc-
tion of the length of time until restoring continuity in
those with a temporary enterostomy, as well as being
more liberal with primary anastomosis in some situations
(i.e., diverticulitis) may improve long-term HR-QoL.
We assessed HR-QoL using a generic questionnaire, which
enabled us to make comparisons to the general popula-
tion and other diseases populations [22]. The EQ-5D and
EQ-VAS have also been recommended as the choice of
generic HR-QoL patient groups, and well validated. None-
theless, applying a disease-specific questionnaire, includ-
ing peritonitis specific symptoms and complaints, may
allow for more insight into possible factors that may not
be detected by a generic HR-QoL instrument [24,45].
It may be a viable option that hospitals consider investing
into a tailored support network for patients with more
lengthy hospitalization stays, to better prepare both the
patient and the home caregivers for the period following
discharge characterized by diminished HR-QoL. Younger
patients of working age and patients with existing major
comorbidity seem to warrant more psychosocial support
when discharged from the hospital, which could in turn
enable them to return to the workforce more quickly and
reduce costs due to loss of productivity. Once the acute
life-threatening situation has dissipated and patients are
in the surgical ward or have been discharged there may be
ample opportunities to consider the patients' psychoso-
cial network. The results also suggest that this support
should be aimed at all peritonitis patients, irrespective of
their severity of illness at presentation, since their at six
months HR-QoL is not different from those with a seemly
more favorable presentation, as severity of peritonitis is
not an important indicator of later HR-QoL.
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Appendix 1
RELAP trial clinical centers and investigators of the Dutch
Peritonitis Study Group (from the Department of Surgery,
Academic Medical Center Amsterdam, The Netherlands).
All investigators are from Departments of Surgery unless
specified (E) Clinical Epidemiology and Biostatistics (E)
or (I) Intensive Care or Medical Psychology (MP).
O van Ruler, KR Boer (E), JB Reitsma (E), CW Mahler, EA
Reuland, JWO van Till, BC Opmeer (E), PMM Bossuyt (E),
MJ Schultz (I), MA Sprangers (MP), H Obertop, DJ
Gouma, CAJM de Borgie (E), MA Boermeester, Academic
Medical Center, Amsterdam; EPh Steller, P. Tanis, H Hart
(I), St Lucas Andreas Hospital, Amsterdam; MF Gerhards,
M Guijt, HM Oudemans (I), Onze Lieve Vrouwe Gasthuis,
Amsterdam; K. Bosscha, E Ritchie, M Vermeer, Bosch
Medical Centre, Den Bosch, The Netherlands. PW de
Graaf, B van Etten, C Haazer, E Salm (I), Reinier de Graaf
Hospital, Delft; B Lamme, EJ Hesselink, H Rommes (I),
Gelre Hospital, Apeldoorn; RJ Oostenbroek, L te Velde, G
Govaert, HH Ponssen (I), Albert Schweitzer Hospital,
Dordrecht; HG Gooszen, MK Dinkelman, LPH Leenen (I),
University Medical Centre Utrecht; EGJM Pierik, KWW
Lansink, J Bakker (I), Isala Clinics, Zwolle;
Key staff and steering committee at coordinating center
(AMC Amsterdam) RELAP trial:
O van Ruler (study coordinator and investigator), EA Reu-
land (data management), CW Mahler (investigator), JB
Reitsma (epidemiologist), CAJM de Borgie (epidemiolo-
gist), KR Boer (quality of life investigator), BC Opmeer
(economist), MA Boermeester (surgeon, supervisor,
project leader) from the Department of Surgery, Academic
Medical Center Amsterdam, The Netherlands.
Appendix 2: Disease-related morbidity
Non-surgical or conservative treatment of:
•  Fistula  (non-anatomical connection between hollow
organ and cutis or between two hollow organs)
•  Wound dehiscence/incisional hernia (full thickness
discontinuity in abdominal wall with bulging of abdomi-
nal content) with obstruction
• Abscess needing percutanous drainage (pus-contain-
ing non-pre-existing cavity confirmed by positive Gram-
stain or culture)
• Renal failure (urine production < 500 cc/24 h with ris-
ing level of blood urea and creatinin) combined with
dehydration  (decreased circulating volume with raised
hematocrit needing intravenous rehydration) based onHealth and Quality of Life Outcomes 2007, 5:35 http://www.hqlo.com/content/5/1/35
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inadequate oral intake and/or nausea/vomiting. Only
when needing readmission.
• Myocardial infarction (ECG and enzyme changes being
suggestive of MI, needing admission to CCU) or pulmo-
nary embolus(ventilation perfusion mismatch on lung
scintigraphy) or cerebrovascular accident (ischaemic or
non ischaemic with persistent paresis or paralysis without
previous history
•  Gastric or duodenal bleeding (needing endoscopic
treatment or embolisation therapy)
• Respiratory failure (due to pneumonia, pleural effusion
or pulmonary edema needing oxygen therapy or mechan-
ical ventilation)
• Urosepsis (urinary tract infection with positive urine
and blood cultures and circulatory shock)
Surgical intervention for disease-related morbidity
•  Incisional hernia (full thickness discontinuity in
abdominal wall with bulging of abdominal contents with
or without obstruction with disabling complaints interfer-
ing with daily activities, needing surgery)
• Bowel obstruction or herniation due to intra-abdom-
inal adhesions (diagnosis must be confirmed during sur-
gery)
• Burst abdomen (complete midline or transverse discon-
tinuity in abdominal wall)
• Abdominal compartment syndrome (intra-abdominal
hypertension >25 mmHg with tense abdomen and with
increasing respiratory and/or renal failure; measured by
the urinary bladder pressure method (modified Burch cri-
teria)
• Fistula (non-anatomical connection between intestine
and cutis or between two hollow organs needing surgery)
• Intra-abdominal bleeding (Only when septic bleeding
after index laparotomy or relaparotomy or when surgical
bleeding after relaparotomy but not after index laparot-
omy)
• Intraabdominal haematoma (needing surgical evacua-
tion)
• Perforation (of visceral organ; confirmed at surgery)
•  Anastomotic leakage (anastomotic leak on contrast
imaging needing surgery or contrast enhanced CT con-
firmed at relaparotomy)
•  Ischemia or necrosis of a visceral organ (critically
reduced blood flow to an intra-abdominal organ causing
tissue loss; confirmed at pathological examination)
• Enterostomy dysfunction (due to prolaps, stenosis or
retraction)
• Gastric or duodenal ulcer bleeding (needing interven-
tion of any type)
Acknowledgements
Financial support: Supported by the Dutch Organisation for Health Research 
and Development (ZonMW), The Hague, The Netherlands. Health Care 
Efficiency Program Grant number 945-02-028.
References
1. Christou NV, Barie PS, Dellinger EP, Waymack JP, Stone HH: Surgi-
cal Infection Society intra-abdominal infection study. Pro-
spective evaluation of management techniques and
outcome.  Arch Surg 1993, 128:193-198.
2. Koperna T, Schulz F: Prognosis and treatment of peritonitis.
Do we need new scoring systems?  Arch Surg 1996, 131:180-186.
3. Wittmann DH, Schein M, Condon RE: Management of secondary
peritonitis.  Ann Surg 1996, 224:10-18.
4. Haraldsen P, Andersson R: Quality of life, morbidity, and mor-
tality after surgical intensive care: a follow-up study of
patients treated for abdominal sepsis in the surgical inten-
sive care unit.  Eur J Surg Suppl 2003:23-27.
5. Lamme B, Boermeester MA, Belt EJ, van Till JW, Gouma DJ, Obertop
H: Mortality and morbidity of planned relaparotomy versus
relaparotomy on demand for secondary peritonitis.  Br J Surg
2004, 91:1046-1054.
6. Slade E, Tamber PS, Vincent JL: The Surviving Sepsis Campaign:
raising awareness to reduce mortality.  Crit Care 2003, 7:1-2.
7. Quartin AA, Schein RM, Kett DH, Peduzzi PN: Magnitude and
duration of the effect of sepsis on survival. Department of
Veterans Affairs Systemic Sepsis Cooperative Studies
Group.  JAMA 1997, 277:1058-1063.
8. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre
A, Mercier JC, Offenstadt G, Regnier B: Incidence, risk factors,
and outcome of severe sepsis and septic shock in adults. A
multicenter prospective study in intensive care units. French
ICU Group for Severe Sepsis.  JAMA 1995, 274:968-974.
9. Pittet D, Rangel-Frausto S, Li N, Tarara D, Costigan M, Rempe L, Jeb-
son P, Wenzel RP: Systemic inflammatory response syndrome,
sepsis, severe sepsis and septic shock: incidence, morbidities
and outcomes in surgical ICU patients.  Intensive Care Med 1995,
21:302-309.
10. Alberti C, Brun-Buisson C, Goodman SV, Guidici D, Granton J,
Moreno R, Smithies M, Thomas O, Artigas A, Le Gall JR: Influence
of systemic inflammatory response syndrome and sepsis on
outcome of critically ill infected patients.  Am J Respir Crit Care
Med 2003, 168:77-84.
11. Granja C, Dias C, Costa-Pereira A, Sarmento A: Quality of life of
survivors from severe sepsis and septic shock may be similar
to that of others who survive critical illness.  Crit Care 2004,
8:R91-R98.
12. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pin-
sky MR: Epidemiology of severe sepsis in the United States:
analysis of incidence, outcome, and associated costs of care.
Crit Care Med 2001, 29:1303-1310.
13. McLauchlan GJ, Anderson ID, Grant IS, Fearon KC: Outcome of
patients with abdominal sepsis treated in an intensive care
unit.  Br J Surg 1995, 82:524-529.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Health and Quality of Life Outcomes 2007, 5:35 http://www.hqlo.com/content/5/1/35
Page 10 of 10
(page number not for citation purposes)
14. Bosscha K, Reijnders K, Jacobs MH, Post MW, Algra A, van der WC:
Quality of life after severe bacterial peritonitis and infected
necrotizing pancreatitis treated with open management of
the abdomen and planned re-operations.  Crit Care Med 2001,
29:1539-1543.
15. Sloan JA, Cella D, Frost MH, Guyatt G, Osoba D: Quality of life III:
translating the science of quality-of-life assessment into clin-
ical practice-an example-driven approach for practicing cli-
nicians and clinical researchers.  Clin Ther 2003, 25 Suppl
D:D1-D5.
16. Scheingraber S, Kurz T, Dralle H: Short- and long-term outcome
and health-related quality of life after severe peritonitis.
World J Surg 2002, 26:667-671.
17. Juergensen PH, Juergensen DM, Wuerth DB, Finkelstein SH, Steele
TE, Kliger AS, Finkelstein FO: Psychosocial factors and incidence
of peritonitis.  Adv Perit Dial 1996, 12:196-198.
18. Essink-Bot ML, Stouthard ME, Bonsel GJ: Generalizability of valu-
ations on health states collected with the EuroQolc-ques-
tionnaire.  Health Econ 1993, 2:237-246.
19. Brooks R, Kerridge R, Hillman K, Bauman A, Daffurn K: Quality of
life outcomes after intensive care. Comparison with a com-
munity group.  Intensive Care Med 1997, 23:581-586.
20. Dowdy DW, Eid MP, Sedrakyan A, Mendez-Tellez PA, Pronovost PJ,
Herridge MS, Needham DM: Quality of life in adult survivors of
critical illness: A systematic review of the literature.  Intensive
Care Med 2005, 31:611-620.
21. Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM: Who
should measure quality of life, the doctor or the patient?  Br
J Cancer 1988, 57:109-112.
22. Badia X, Diaz-Prieto A, Rue M, Patrick DL: Measuring health and
health state preferences among critically ill patients.  Intensive
Care Med 1996, 22:1379-1384.
23. Angus DC, Carlet J: Surviving intensive care: a report from the
2002 Brussels Roundtable.  Intensive Care Med 2003, 29:368-377.
24. Brooks R, Rabin R, de Charro F, (Eds): The Measurement and Valuation
of Health Status using EQ-5D: A European Perspective; Evidence from the
EuroQol BIOMED Research Programme Edited by: Brooks R, R R and de
Charro F. Dordrecht, Kluwer Academic Publishers; 2003. 
25. EQ-5D, An instrument to describe and value health.  2007
[http://www.euroqol.org]. This website contains information about
the EuroQol Group, membership and research activities, details of
EQ-5D development and current status.
26. Roset M, Badia X, Mayo NE: Sample size calculations in studies
using the EuroQol 5D.  Qual Life Res 1999, 8:539-549.
27. Brooks R: EuroQol: the current state of play.  Health Policy 1996,
37:53-72.
28. Hurel D, Loirat P, Saulnier F, Nicolas F, Brivet F: Quality of life 6
months after intensive care: results of a prospective multi-
center study using a generic health status scale and a satis-
faction scale.  Intensive Care Med 1997, 23:331-337.
29. Tian ZM, Miranda DR: Quality of life after intensive care with
the sickness impact profile.  Intensive Care Med 1995, 21:422-428.
30. Rockwood K, Noseworthy TW, Gibney RT, Konopad E, Shustack A,
Stollery D, Johnston R, Grace M: One-year outcome of elderly
and young patients admitted to intensive care units.  Crit Care
Med 1993, 21:687-691.
31. Boer KR, Mahler CW, Unlu C, Lamme B, Vroom MB, Sprangers MA,
Gouma DJ, Reitsma JB, De Borgie CA, Boermeester MA: Long-term
prevalence of posttraumatic stress disorder symptoms in
patients after secondary peritonitis.  Crit Care 2007, 11:R30.
32. Badia X, Diaz-Prieto A, Gorriz MT, Herdman M, Torrado H, Farrero
E, Cavanilles JM: Using the EuroQol-5D to measure changes in
quality of life 12 months after discharge from an intensive
care unit.  Intensive Care Med 2001, 27:1901-1907.
33. Garcia-Lizana F, Peres BD, De Cubber M, Vincent JL: Long-term
outcome in ICU patients: what about quality of life?  Intensive
Care Med 2003, 29:1286-1293.
34. Koperna T, Semmler D, Marian F: Risk stratification in emer-
gency surgical patients: is the APACHE II score a reliable
marker of physiological impairment?  Arch Surg 2001,
136:55-59.
35. Bohnen JM, Mustard RA, Oxholm SE, Schouten BD: APACHE II
score and abdominal sepsis. A prospective study.  Arch Surg
1988, 123:225-229.
36. Wehler M, Geise A, Hadzionerovic D, Aljukic E, Reulbach U, Hahn
EG, Strauss R: Health-related quality of life of patients with
multiple organ dysfunction: individual changes and compari-
son with normative population.  Crit Care Med 2003,
31:1094-1101.
37. Granja C, Teixeira-Pinto A, Costa-Pereira A: Quality of life after
intensive care--evaluation with EQ-5D questionnaire.  Inten-
sive Care Med 2002, 28:898-907.
38. RM Kleinpell: Exploring outcomes after critical illness in the
elderly.  Outcomes Manag 2003, 7:159-169.
39. Vedio AB CS Warburton FG,Griffiths MP,Leach RM,Treacher DF:
Assessment of survival and quality of life after discharge
from a teaching hospital general intensive care unit.  Clin Inten-
sive Care 2000, 11:39-46.
40. Pettila V, Kaarlola A, Makelainen A: Health-related quality of life
of multiple organ dysfunction patients one year after inten-
sive care.  Intensive Care Med 2000, 26:1473-1479.
41. Graf J, Koch M, Dujardin R, Kersten A, Janssens U: Health-related
quality of life before, 1 month after, and 9 months after
intensive care in medical cardiovascular and pulmonary
patients.  Crit Care Med 2003, 31:2163-2169.
42. Kvale R, Flaatten H: Changes in health-related quality of life
from 6 months to 2 years after discharge from intensive
care.  Health Qual Life Outcomes 2003, 1:2.
43. Sage WM, Rosenthal MH, Silverman JF: Is intensive care worth it?
An assessment of input and outcome for the critically ill.  Crit
Care Med 1986, 14:777-782.
44. Stricker KH, Cavegn R, Takala J, Rothen HU: Does ICU length of
stay influence quality of life?  Acta Anaesthesiol Scand 2005,
49:975-983.
45. Dowie J: Decision validity should determine whether a
generic or condition-specific HRQOL measure is used in
health care decisions.  Health Econ 2002, 11:1-8.